Titanium dioxide nanoparticles exacerbate pneumonia in respiratory syncytial virus (RSV)-infected mice

Environ Toxicol Pharmacol. 2015 Mar;39(2):879-86. doi: 10.1016/j.etap.2015.02.017. Epub 2015 Mar 3.

Abstract

To reveal the effects of TiO2 nanoparticles, used in cosmetics and building materials, on the immune response, a respiratory syncytial virus (RSV) infection mouse model was used. BALB/c mice were exposed once intranasally to TiO2 at 0.5mg/kg and infected intranasally with RSV five days later. The levels of IFN-γ and chemokine CCL5, representative markers of pneumonia, in the bronchoalveolar lavage fluids of RSV-infected mice had increased significantly in TiO2-exposed mice compared with the control on day 5 post-infection, but not in uninfected mice. While pulmonary viral titers were not affected by TiO2 exposure, an increase in the infiltration of lymphocytes into the alveolar septa in lung tissues was observed. Immunohistochemical analysis revealed aggregation of TiO2 nanoparticles near inflammatory cells in the severely affected region. Thus, a single exposure to TiO2 nanoparticles affected the immune system and exacerbated pneumonia in RSV-infected mice.

Keywords: Nanoparticles; Pneumonia; Respiratory syncytial virus; Titanium dioxide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid / cytology
  • Bronchoalveolar Lavage Fluid / immunology
  • Cell Line, Tumor
  • Cytokines / blood
  • Cytokines / immunology
  • Female
  • Humans
  • Lung / drug effects
  • Lung / immunology
  • Lung / virology
  • Mice, Inbred BALB C
  • Nanoparticles / toxicity*
  • Pneumonia / immunology*
  • Pneumonia / virology
  • Respiratory Syncytial Virus Infections / immunology*
  • Respiratory Syncytial Virus Infections / virology
  • Respiratory Syncytial Viruses / isolation & purification
  • Titanium / toxicity*
  • Viral Load
  • Viral Proteins / analysis

Substances

  • Cytokines
  • Viral Proteins
  • titanium dioxide
  • Titanium